[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-HURA":3,"homepage-market-summary":31,"stock-news-HURA":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"HURA","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"TuHURA Biosciences, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.","22","Tampa, FL",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},1.91,2,2.0499,1.88,1.98,-0.07,-3.54,287148.719329,2340,1.9409,3.43,0.41,782418.590728048,49.7,3424,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":155},"success",[34,42,49,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":40,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":14,"sparkline":76,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":40,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":40,"sparkline":91,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":40,"sparkline":98,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":40},"Technology","XLK",1.01,199.81,{"name":106,"etf":107,"change":108,"price":109,"is_up":40},"Financials","XLF",0.06,53.49,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",1.13,110.04,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.25,80.53,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.4,62.95,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.78,169.95,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",0.66,48.86,{"name":141,"etf":142,"change":143,"price":144,"is_up":40},"Real Estate","XLRE",0.32,40.81,{"name":146,"etf":147,"change":148,"price":149,"is_up":40},"Utilities","XLU",0.38,39.83,{"name":151,"etf":152,"change":153,"price":154,"is_up":40},"Comm Services","XLC",0.35,110.32,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":40},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":162,"name":163,"price":164,"change":90,"is_up":40},"QQQ","Invesco QQQ Trust",749.58,{"ticker":166,"name":167,"price":168,"change":54,"is_up":40},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":170,"name":171,"price":172,"change":68,"is_up":40},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":174,"articles":175},6,[176,182,188,194,198,204],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"A cancer patent also covers cell-based treatments, not just antibody-linked drugs - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxPaE16MDZobzRZeU1DcERLVi1mRWpBVjJnSjl3UDAtc09QLUNGRHlJUlpNU3QxaXBOcWNCT0FJaU9NYzByTmN5RkxaV1RiQ3ZaMmhqeEY5cWRwWWF5dnpiZVF4TVN2SnpxX2NqOXNJUVNzVlV2Z21OcDlTb3E4QzlaUUx2MzEyS3VPNndNNzJ1dWJzVnVrOHBub3ZlUjktMDlpNUc3VVRyZE04WlcxQmVoaHBtOGtBSXQtRTRvNHJn?oc=5","Mon, 05 Oct 2026 11:45:00 GMT","A cancer patent also covers cell-based treatments, not just antibody-linked drugs Stock Titan","Stock Titan",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"Oracle gave Larry Ellison and his co-CEOs nearly $1 billion in stock options. By fiscal year end, all were underwater - Fortune","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMibEFVX3lxTFBVaHRnbjZTVWhCV2JyZDFYNG13cVdZY3FlQ3A5OTVfa2pmRjh5WWpadk1aTHFoRzVYQzNZWUg2dUVrRkJGcmN4WXBUQXhkcEVjTi1aNWlxa1psNWdVT3NGLWd0OVNPX3NkeTNxeQ?oc=5","Sat, 26 Sep 2026 07:00:00 GMT","Oracle gave Larry Ellison and his co-CEOs nearly $1 billion in stock options. By fiscal year end, all were underwater Fortune","Fortune",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"Citizens reiterates TuHURA Biosciences stock rating on AML therapy progress - Investing.com UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0gFBVV95cUxPU3N1TVZlVUpWc1h5QVZxWlNYTkZsaXZMdDJ2ejFwU2MzYkdLV3RJbmNmUkJQcXl5ejJWTmxGZmZmUHJMYnJnQm1LdzZDQ3FwT21WX1NickhwWjJGSEUtcnZhZ3FzVnVCWUNGSS1oNXBfNGpXNFlmaW9sczVEVkplcklrcGNvY1lyYUFEZWgtNnhRbmk0UjZ0ckg2LV9QZ0Y3Zmw4RjBkNmpLT0o5VHZ4TGo2b1BnalVuV2R4cFBjblZHbFNBelppM1hwX09oM2w2anc?oc=5","Wed, 23 Sep 2026 07:00:00 GMT","Citizens reiterates TuHURA Biosciences stock rating on AML therapy progress Investing.com UK","Investing.com UK",{"title":195,"link":196,"pubDate":191,"description":197,"source":181},"Oracle (NYSE: ORCL) executive Mark Hura has 8,456 and 20,805 shares withheld for taxes. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqAFBVV95cUxNS2Zmd1lwZHdJaGZZTnZWVkt4ajBaTy1oMVFVcDJBZF92SzRvMUhEMXNuUU9nTmR2MEwtWGh1VjBHRHh2V3JnRXVEWDJWdkxLLUxUY3djOWh0TEdtbVo2VXBkek9JX19qWkF5OXRVcEVVR1VpX2pOLWU3TDhZQVAwOFNJTHp3SFJZUE5ybm1MRm5oSkJ0ckNpZUxLWjBBZ2xDWlBUYm1tSXU?oc=5","Oracle (NYSE: ORCL) executive Mark Hura has 8,456 and 20,805 shares withheld for taxes. Stock Titan",{"title":199,"link":200,"pubDate":201,"description":202,"source":203},"TuHURA Biosciences receives U.S. patent for DOR technology By Investing.com - Investing.com India","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxQck14ZlY2Q2hBU21Db093MWwzaEp1WTJ2RUx2ejJtbTYyQ0xtbmpyT29RQU8tLXliaFlidUJXeE9qZEhPaEplM05raWN5TjF1dVFvTjFKalYxSUhaYVRVNDRuT2ZxZGNlMUpTRExDRmtLdTE3anRUeWRlalZxQXR5dnB6czdsOTg0bGxGV3VZemhWN1dWaUVabG1IQTVQV2FTX3QyVDQzQVFySVJxaDMteUM5bElKdzBI?oc=5","Mon, 05 Oct 2026 11:52:42 GMT","TuHURA Biosciences receives U.S. patent for DOR technology By Investing.com Investing.com India","Investing.com India",{"title":205,"link":206,"pubDate":207,"description":208,"source":209},"TuHURA Biosciences Draws Additional Funds From Credit Facility - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxORFlqVngyWldhSnNOdV9JQi0zSnJiMU9RRjhxTFBvMjh4STBVMkYxTWUwOE1uNGhGZjNEcnpaXzlOZE5RR2gzVEZfcllhVERhY2Nxa1VQeEhZQS1yb0pjN2REd1ppN1NHakNNcGJnRlBkTmpDVkVwNEhMSkRXbzNmUWxfZFlQeHhHdDZsZXZLVi1CTFFVMnlFQkhJc2hzMEY5MUxwN0x2b1dJRFdPbTJCODV0LVlSTFE?oc=5","Thu, 24 Sep 2026 07:00:00 GMT","TuHURA Biosciences Draws Additional Funds From Credit Facility TipRanks","TipRanks"]